Metformin reverses fatty liver disease in obese, leptin-deficient mice

Nature Medicine

Volumn 6, Issue 9, 2000, Pages 998-1003

  Lin, Hui Zhi ^a   Yang, Shi Qi ^a   Chuckaree, Christine ^a   Kuhajda, Francis ^b   Ronnet, Gabriele ^b,c   Diehl, Anna Mae ^a  

^a John Hopkins Medical Instituitions   (United States)

^b PCTB 1007 ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINOTRANSFERASE; LEPTIN; METFORMIN; TUMOR NECROSIS FACTOR;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FATTY LIVER; HEPATOMEGALY; HISTOPATHOLOGY; INSULIN RESISTANCE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; STEATOSIS; TREATMENT OUTCOME;

ADENOSINE TRIPHOSPHATE; ADIPOSE TISSUE; ANIMAL; BODY WEIGHT; ENERGY INTAKE; ENERGY METABOLISM; FATTY LIVER; HEPATOMEGALY; HOMEOSTASIS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPIDS; METFORMIN; MICE; MICE, OBESE; OBESITY; TRANSAMINASES; TUMOR NECROSIS FACTOR;

EID: 0012785395     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/79697     Document Type: Article

References (44)

1. el-Hassan, A.V., Ibrahim, E.M., al-Mulhim, F.A., Nabhan, A.A. & Chammas, M.Y. Fatty infiltration of the liver: analysis of prevalence, radiological and clinical findings. Br. J. Radiol. 65, 774-778 (1992).
2. Bellentani, S. et al. Prevalence of chronic liver disease in the general population of Northern Italy: The Dionysis study. Hepatology 20, 1442-1449 (1994).
3. Marchesini, G. et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107, 450-455 (1999)
4. Sheth, S.G., Cordon, F.D. & Chopar, S. Nonalcoholic steatohepatitis. Ann. Intern. Med. 126, 137-145 (1997).
5. Matteoni, C., Younossi, Z.M. & McCullough, A. Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology 116, 1413-1419 (1999).
6. Marceau, P. et al. Liver pathology and metabolic syndrome X in severe obesity. J Clin. Endocrinol. Metab. 84, 1513-1517 (1999).
7. Yang, S.Q., Lin, H.Z., Lane, M.D., Clemens, M. & Diehl, A.M. Obesity increases sensitivity of endotoxin liver injury: implications for pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94, 2557-2562 (1997).
8. Kushi, A. et al. Obesity and mild hyperinsulinemia found in neuropeptide Y-U1 receptor deficient mice. Proc. Natl. Acad. Sci USA 95, 15659-15664 (1998).
9. Shimomura, I. et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182-3194 (1998).
10. DeFronzo, R.A., Barzilai, N. & Simonson, D.C. Mechanism of metformin action in obese and lean non-insulin dependent diabetics subjects. J. Clin. Endocrinol. Metab. 73, 1294-1301 (1991).
11. Stumvoll, M., Nurjhan, N., Perriello, C., Dailey, G. & Gerich, J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 333, 550-554 (1995).
12. Cusi, K., Consoli, A. & DeFronzo, R.A. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol Metab. 81, 4059-4067 (1996).
13. Wiernsperger, N.F. & Bailey, C.J. The anti-hyperglycemic effect of metformin. Drugs 58, 31-39 (1999).
14. Meglasson, M.D. et al. Anti hyperglycemic actions of guanidenoalkanoic acids: 3-guanidinopropionic acid ameliorates hyperglycemia in diabetic KKAy and C57BL-6J ob/ob mice and increases glucose disappearance in rhesus monkeys. J. Pharmacol. Exp. Ther. 266, 1454-1462 (1993).
15. Uysal, K.T., Wiesbrock, S.M., Marino, M.W. & Hotamisligil, G.S. Protection from obesity-induced insulin-resistance in mice lacking TNFα function. Nature 389, 610-614 (1997).
16. Campfield, L.A., Smith, F.J. & Burn, P. The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks. Horm. Metab. Res. 28, 619-632 (1996).
17. Rouru, J., Pesonen, V. & Koulu, M. Subchronic treatment with metformin produces anorectic effect and reduces hyperinsulinemia in genetically obese Zucker rats. Life Sci. 50, 1813-1820 (1992)
18. Paolisso, G. et al. Effect of metformin on food intake in obese subjects. Eur. J. Clin. Invest. 28, 441-446 (1998).
19. Shulman, G.I. Cellular mechanisms of insulin resistance in humans. Am. J. Cordiol. 84, 3J-10J (1999).
20. Holleneck, C.B., Johnston, P., Varasteh, B.B., Chen, V.D. & Reaven, G.M. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridemia and non-insulin dependent diabetes by glucose tolerance test criteria. Diabete Metab. 17, 483-489 (1991).
21. Huupponen, R., Pyykko, K., Koulu, M. & Rouru, J. Metformin and liver glycogen synthase activity in obese Zucker rats. Res. Commun. Chem. Pathol. Pharmacol. 79, 219-227 (1993).
22. Ricquier, D. Neonatal brown adipose tissue, UCP-1 and the novel uncoupling proteins. Biochem. Soc. Trans. 26, 120-123 (1998).
23. Solomon, S. S., Mishra, S.K., Cwik, C., Rajanna, B. & Postlethwaite, A.E. Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells. Horm. Metab. Res. 29, 379-382 (1997).
24. Cortez-Pinto, H. et al. Bacterial lipopolysaccharide induces uncoupling protein-2 in hepatocytes via a tumor necrosis factor alpha-dependent mechanism. Biochem. Biophys. Res. Commun. 251, 313-319 (1998).
25. Lawler, J.F., Yin, M., Diehl, A.M., Roberts, E. & Chatterjee, S. Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 through the actions of neutral sphingomyleinase. J. Biol. Chem. 273, 5053-5059 (1998).
26. Chavin, K. et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem. 274, 5692-5700 (1999).
27. Zaibi, M.D. et al. Metformin induces an agonist-specific increase in albumin production by primary cultured rat hepatocytes. Biochem. Pharmacol. 50, 775-780 (1995).
28. Shimomura, I., Bashmakow, Y. & Horton, J.D. Increased nuclear levels of SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J. Biol. Chem. 274, 30028-30032 (1999).
29. Perriello, C. et al. Acute anti hyperglycemic actions of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes 43, 920-928 (1994).
30. Purrello, F. et al. Metformin enhances certain insulin actions in cultured rat hepatoma cells. Diabetologia 31, 385-389 (1988).
31. Melin, B. et al. Dual effect of metformin in cultured rat hepatocytes. potentiation of insulin action and prevention of insulin-induced resistance. Metabolism 39, 1089-1095 (1990).
32. Hotamisligil, C.S. et al. IRS-I mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 271, 665-668 (1996).
33. McClain, C.J., Hill, D.B., Schmidt, J. & Diehl, A.M. Cytokines and alcoholic liver disease. Semin. Liv. Dis. 13, 170-182 (1993).
34. Yin, M. et al. Essential role of tumor necrosis factor-alpha in alcohol-induced liver injury in mice. Castroenterology 117, 942-952 (1999).
35. Shimomura, E., Bashmakov, Y. & Horton, J.D. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. J. Biol. Chem. 274, 30028-30032 (1999).
36. Cortez-Pinto, H., Lin, H.Z., Yang, S.Q., Odwin da Costa, S. & Diehl, A.M. Lipids upregulate uncoupling protein-2 expression in rat hepatocytes. Gastroenterology 116, 1184-1193 (1999).
37. Ni, N. & Yager, J. Co-mitogenic effects of estrogens on DNA synthesis induced by various growth factors in cultured female hepatocytes. Hepatohgy 19, 182-190 (1994).
38. Diehl, A.M. et al. Tumor necrosis factor induces c-jun during the regenerative response to liver injury. Am. J. Physiol. 267, G552-G561 (1994).
39. Pizer, E.S. et al. Malonyl-coenzyme A is a potential mediator of cytotoxicity induced by fatty acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 60, 213-218 (2000).
40. Chomczynski, P., Sacchi, N. Single step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal. Biochem 162, 156-161 (1987).
41. Yang, S.Q. et al. Mitochondrial adaptations to oxidative stress in obesity-related fatty livers. Arch, Biochem. Biophys. 378, 259-268 (2000).
42. Lavery, D.J. & Schibler, U. Circadian transcription of the 7 alpha hydroxylase gene may involve the liver-enriched bZIP protein DBP. Genes Dev. 7, 1871-1884 (1993).
43. Dawson, P.A. et al. Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor SP1. J. Biol. Chem. 263, 3372-3379 (1988).
44. Alo, P.L. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77, 474-482 (1996).